Market Overview

Endologix Q4 Earnings Preview


Endologix (NASDAQ: ELGX) announces its next round of earnings Wednesday. Here is Benzinga's everything-that-matters guide for today's Q4 earnings announcement.

Earnings and Revenue

Based on Endologix management projections, analysts predict an earnings loss of 21 cents per share on revenue of $45 million.

Endologix EPS in the same period a year ago was a loss of 22 cents. Revenue was $47 million. If the company were to match the consensus estimate when it reports Wednesday, earnings would be down 4.55 percent. Sales would be down 5.02 percent on a year-over-year basis.

The company's reported EPS has stacked up against analyst estimates in the past like this:


Quarter Q3 2017 Q2 2017 Q1 2017 Q4 2016
EPS Estimate -0.17 -0.18 -0.21 -0.19
EPS Actual -0.11 -0.1 -0.18 -0.22


Stock Performance

Over the last 52-week period, shares are down -37.25 percent. Given that these returns are generally negative, long-term shareholders are probably unhappy going into this earnings release.

Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. Analysts have been rating Endologix stock as Neutral. The strength of this rating has maintained conviction over the past three months.

Conference Call

Endologix's Q4 is scheduled to hold a conference call at 4:30 p.m. ET and it can be accessed here.


Related Articles (ELGX)

View Comments and Join the Discussion!

Posted-In: Earnings News Previews Trading Ideas